$1.82 -0.09 (-4.71%)
11/27/2009 1:00 PM

Array BioPharma, Inc. (ARRY)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Featured Broker Partners